Michael Cannon

Neil McCluskey, Director of the Center for Educational Freedom, and Michael Cannon, Director of Health Policy Studies, engage in a lively debate over which sector—education or healthcare—has suffered more from government intervention. McCluskey highlights the monopolistic grip on K-12 education, threatening individual freedom, while Cannon argues that healthcare's dysfunction stems from costly government regulations. They explore how subsidies inflate costs and envision libertarian solutions for both sectors, advocating for more choice and personal accountability.

Michael Cannon, Director of health policy studies at the Cato Institute, dives into the powerful potential of Health Savings Accounts (HSAs), not just for health care but also for retirement savings. He highlights the significant tax benefits HSAs offer and how they can be leveraged for long-term financial growth. Cannon discusses the importance of policy reforms to make HSAs more accessible and flexible, empowering individuals while also advocating for higher contribution limits. Finally, he emphasizes HSAs as a dual-purpose tool, combining health expenditure funding with investment opportunities.

Michael F. Cannon, Director of Health Policy Studies at the Cato Institute, and Romina Boccia, Director of Budget and Entitlement Policy, dive deep into the ramifications of the recent 43-day government shutdown. They discuss the contentious focus on Obamacare subsidies for high earners and examine the frailty of federal systems like SNAP and air traffic control. The conversation highlights the perils of centralized control and the need for decentralized solutions to prevent future shutdowns, offering insights on potential budgetary reforms and political dynamics.

Michael Cannon, Director of Health Policy Studies at Cato, and Dominik Lett, Budget Policy Analyst, dive into the complexities of a monumental piece of legislation affecting Medicaid and federal debt. They unpack the financial fog surrounding the bill, questioning if it really costs $3.4 trillion or $6 trillion. The conversation highlights how spending cuts are delayed while tax benefits are prioritized, revealing the political maneuvers behind the scenes. They also scrutinize the implications of Medicaid changes and their potential burden on the federal budget.

Michael F. Cannon, director of health policy studies at the Cato Institute, shares insightful perspectives on government involvement in healthcare. He explores the origins of medical licensing, arguing it creates monopolies that elevate costs and limit access. Cannon discusses the historical roots of tax breaks for employer-sponsored insurance, emphasizing how these distort markets. The conversation also highlights the impact of FDA regulations on drug safety, and the potential of market innovations like telehealth to improve care accessibility.

Michael Cannon, an expert on health care policy, discusses the growing issue of government overreach in the healthcare sector. He critiques the lack of substantial reform plans from both Donald Trump and Kamala Harris, pointing out their failure to address the inefficacy of current government interventions. The conversation dives into the opaque nature of healthcare pricing and the importance of consumer empowerment to foster transparency and lower costs. Cannon emphasizes that without meaningful change, fiscal burdens will only increase.

Michael Cannon, the director of health policy studies at the Cato Institute, returns to discuss the complexities of the American healthcare system. He emphasizes how misconceptions around free markets affect health outcomes and argues that unfettered markets can greatly enhance access to care. Cannon critiques government interventions that distort pricing and leave patients worse off. He shares insights on the lifecycle of medical innovation and stresses the need for price transparency, leaving listeners hopeful for a more efficient healthcare landscape.

Brian Blase, chief of Paragon Health Institute, and Michael Cannon from Cato discuss the fiscal challenges of Medicare. They explore funding issues, lobbying dynamics, and propose reforms for cost control and quality care. The podcast highlights the resistance to cutting Medicare spending, misconceptions about the Medicare Trust Fund, and the impact of recent legislation on rising debt levels.

Michael Cannon, a FDA policy expert discusses the impact of FDA's delays in approving contraception on women's economic gains. They explore how FDA regulations create barriers to access and affordability, and the negative impact of FDA's delays on drug approval and prices.

Michael Cannon, Director of health policy studies at the Cato Institute and an expert on health savings accounts, delves into the transformative potential of HSAs in American healthcare. He explains how these accounts empower individuals to make personal healthcare choices, shifting power from employers. Cannon also highlights the tax advantages and flexibility of HSAs as savings tools. He shares a California experiment that showcased how HSAs encourage cost-conscious behavior among patients, leading to increased competition and lower healthcare costs.